Ipamorelin is a synthetic peptide that stimulates growth hormone release through a different receptor pathway than CJC-1295, and is often used alongside it. It is marketed similarly, for muscle gain, fat loss and recovery.
It has a demonstrated effect on growth hormone release in available studies, and is considered by some researchers to be more selective (fewer effects on other hormones like cortisol) than older growth hormone secretagogues. Evidence for meaningful, safe outcomes from general consumer use remains limited.
Similar to other growth hormone secretagogues: potential effects on blood sugar and fluid balance, unverified purity and dosing as an unregulated product, and no established long-term human safety data.
Legal and research status: this peptide is typically sold as a research chemical, labelled not for human consumption, and is not an approved medicine or supplement in the UK, EU or US. Buying it for personal use sits in a legal grey area, and product purity and dosing are not independently verified or regulated. As with other growth hormone peptides, this affects a significant hormonal axis and is not appropriate for self-directed use without medical oversight.
Sold online as a research chemical, priced per vial.
Pharmacology research on growth hormone secretagogue selectivity. Educational information only. Not an approved medicine.